PL3784215T3 - Miękka kapsułka żelowa zawierająca selektywny modulator receptora estrogenowego - Google Patents
Miękka kapsułka żelowa zawierająca selektywny modulator receptora estrogenowegoInfo
- Publication number
- PL3784215T3 PL3784215T3 PL19721535.3T PL19721535T PL3784215T3 PL 3784215 T3 PL3784215 T3 PL 3784215T3 PL 19721535 T PL19721535 T PL 19721535T PL 3784215 T3 PL3784215 T3 PL 3784215T3
- Authority
- PL
- Poland
- Prior art keywords
- estrogen receptor
- receptor modulator
- selective estrogen
- soft gel
- gel capsule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20180100177A GR1009542B (el) | 2018-04-25 | 2018-04-25 | Καψουλα μαλακης γελης που περιλαμβανει εναν εκλεκτικο ρυθμιστη οιστρογονικων υποδοχεων |
| PCT/EP2019/025117 WO2019206458A1 (en) | 2018-04-25 | 2019-04-23 | Soft gel capsule comprising a selective estrogen receptor modulator |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3784215T3 true PL3784215T3 (pl) | 2025-11-17 |
Family
ID=66397189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19721535.3T PL3784215T3 (pl) | 2018-04-25 | 2019-04-23 | Miękka kapsułka żelowa zawierająca selektywny modulator receptora estrogenowego |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20210236437A1 (pl) |
| EP (1) | EP3784215B1 (pl) |
| DK (1) | DK3784215T3 (pl) |
| ES (1) | ES3042565T3 (pl) |
| FI (1) | FI3784215T3 (pl) |
| GR (1) | GR1009542B (pl) |
| HR (1) | HRP20251168T1 (pl) |
| HU (1) | HUE073197T2 (pl) |
| LT (1) | LT3784215T (pl) |
| PL (1) | PL3784215T3 (pl) |
| PT (1) | PT3784215T (pl) |
| RS (1) | RS67262B1 (pl) |
| SI (1) | SI3784215T1 (pl) |
| SM (1) | SMT202500357T1 (pl) |
| WO (1) | WO2019206458A1 (pl) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9418067D0 (en) | 1994-09-07 | 1994-10-26 | Orion Yhtymae Oy | Triphenylethylenes for the prevention and treatment of osteoporosis |
| GB9604577D0 (en) | 1996-03-04 | 1996-05-01 | Orion Yhtymae Oy | Serum cholesterol lowering agent |
| KR100587551B1 (ko) | 1997-12-10 | 2006-06-08 | 싸이클로스포린 테라퓨틱스 리미티드 | 오메가-3 지방산 오일을 함유하는 약학 조성물 |
| US8236861B2 (en) | 2004-02-13 | 2012-08-07 | Hormos Medical Corporation | Method for enhancing the bioavailablity of ospemifene |
| US9532963B2 (en) | 2009-03-09 | 2017-01-03 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof |
| PL2519230T3 (pl) | 2009-12-31 | 2019-05-31 | Marius Pharmaceuticals Llc | Modulacja rozpuszczalności, stabilności, absorpcji, metabolizmu i profilu farmakokinetycznego leków lipofilowych przez sterole |
| EP3423047A4 (en) * | 2016-03-04 | 2020-01-01 | Sharon Anavi-Goffer | COMPOSITIONS OF CB2 RECEPTOR SELECTIVE AGONISTS FOR THE TREATMENT OF MENTAL DISEASES |
| US10857127B2 (en) * | 2016-05-20 | 2020-12-08 | Azure Biotech, Inc. | Vaginal delivery systems containing selective estrogen receptor modulator (SERM) and uses thereof |
-
2018
- 2018-04-25 GR GR20180100177A patent/GR1009542B/el active IP Right Grant
-
2019
- 2019-04-23 EP EP19721535.3A patent/EP3784215B1/en active Active
- 2019-04-23 RS RS20250979A patent/RS67262B1/sr unknown
- 2019-04-23 ES ES19721535T patent/ES3042565T3/es active Active
- 2019-04-23 SM SM20250357T patent/SMT202500357T1/it unknown
- 2019-04-23 SI SI201930973T patent/SI3784215T1/sl unknown
- 2019-04-23 PL PL19721535.3T patent/PL3784215T3/pl unknown
- 2019-04-23 LT LTEPPCT/EP2019/025117T patent/LT3784215T/lt unknown
- 2019-04-23 HU HUE19721535A patent/HUE073197T2/hu unknown
- 2019-04-23 US US17/049,795 patent/US20210236437A1/en not_active Abandoned
- 2019-04-23 HR HRP20251168TT patent/HRP20251168T1/hr unknown
- 2019-04-23 FI FIEP19721535.3T patent/FI3784215T3/fi active
- 2019-04-23 DK DK19721535.3T patent/DK3784215T3/da active
- 2019-04-23 WO PCT/EP2019/025117 patent/WO2019206458A1/en not_active Ceased
- 2019-04-23 PT PT197215353T patent/PT3784215T/pt unknown
-
2022
- 2022-11-07 US US18/053,010 patent/US20230073855A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SI3784215T1 (sl) | 2025-11-28 |
| EP3784215A1 (en) | 2021-03-03 |
| FI3784215T3 (fi) | 2025-10-14 |
| EP3784215B1 (en) | 2025-07-09 |
| RS67262B1 (sr) | 2025-10-31 |
| GR1009542B (el) | 2019-06-07 |
| WO2019206458A1 (en) | 2019-10-31 |
| US20230073855A1 (en) | 2023-03-09 |
| LT3784215T (lt) | 2025-10-27 |
| HRP20251168T1 (hr) | 2025-11-21 |
| PT3784215T (pt) | 2025-10-14 |
| ES3042565T3 (en) | 2025-11-21 |
| HUE073197T2 (hu) | 2026-01-28 |
| US20210236437A1 (en) | 2021-08-05 |
| SMT202500357T1 (it) | 2025-11-10 |
| DK3784215T3 (da) | 2025-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL295598A (en) | Selective estrogen receptor antagonists | |
| IL268319A (en) | Benzothiophene estrogen receptor modulators | |
| IL279990A (en) | Selective estrogen receptor antagonists | |
| IL268263B (en) | Estrogen receptor modulators | |
| ZA202005324B (en) | Mixing device comprising a seal | |
| GB2585803B (en) | Electro-absorption modulator | |
| ZA202201157B (en) | Selective estrogen receptor degrader | |
| IL292477B1 (en) | Eardrum therapy device | |
| PL3458015T3 (pl) | Systemy dopochwowe zawierające selektywny modulator receptora estrogenowego (serm) i ich zastosowania | |
| GB2576050B (en) | Pressure fill system | |
| HUE073197T2 (hu) | Szelektiv ösztrogén receptor modulátort tartalmazó lágyzselékapszula | |
| ZA201802863B (en) | Soft gel capsule comprising a selective estrogen receptor modulator | |
| IL257363A (en) | Combined comb-scissor device for books | |
| GB2597407B (en) | Filling device | |
| GB2606065B (en) | Pressure fill system | |
| PT3883865T (pt) | Vedação de uma cápsula de porção única | |
| HU5271U (hu) | Töltõeszköz | |
| HK40018940A (en) | Benzothiophene estrogen receptor modulators | |
| ZAA201801446S (en) | A capsule | |
| PH32018000897S1 (en) | Capsule | |
| GB201806710D0 (en) | Capsule |